GOLDMAN SACHS GROUP INC

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 886982 NEW YORK, NY

Position in ORMP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,218,339

+$817,397 QoQ

Shares Held

253,293

+64.9% QoQ

Ownership

0.609%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 84 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. ORMP ranks #247 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,218,339	253,293	+64.9%	Shares	Defined	2026-08-14
2023-09-30	$400,942	153,618	+69.0%	Shares	Defined	2024-05-15
2023-06-30	$325,475	90,915	-9.9%	Shares	Defined	2024-05-14
2023-03-31	$220,079	100,954	+511.6%	Shares	Defined	2024-05-14
2022-12-31	$198,579	16,507	-69.9%	Shares	Defined	2024-05-14
2022-09-30	$355,764	54,902	+93.6%	Shares	Defined	2024-05-14
2022-06-30	$129,902	28,363	-59.6%	Shares	Defined	2024-05-14
2022-03-31	$607,082	70,183	-40.0%	Shares	Defined	2022-05-16
2021-12-31	$1,671,244	117,034	+492.0%	Shares	Defined	2022-02-17
2021-09-30	$434,500	19,768	-43.6%	Shares	Defined	2022-01-20
2021-06-30	$469,035	35,055	+77.4%	Shares	Defined	2021-08-13
2021-03-31	$200,710	19,755	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.